Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial

Authors:

Abstract
No abstract available
Funding Information
  • Universityof CapeTown
  • Bill and Melinda Gates Foundation
  • Wellcome Trust (221698/Z/20/Z)

This publication has 21 references indexed in Scilit: